Prostatic cancer: the response to treatment dilemma.
出版信息
Br Med J. 1980 Mar 29;280(6218):883-4. doi: 10.1136/bmj.280.6218.883.
Abstract
摘要
相似文献
1
Prostatic cancer: the response to treatment dilemma.
Br Med J. 1980 Mar 29;280(6218):883-4. doi: 10.1136/bmj.280.6218.883.
2
[Importance of serum acid phosphatase for the prognosis of prostatic carcinoma].[血清酸性磷酸酶对前列腺癌预后的重要性]
Z Urol Nephrol. 1971 Apr;64(4):249-56.
3
[Early diagnosis of metastases in prostatic carcinoma].[前列腺癌转移的早期诊断]
Dtsch Med Wochenschr. 1972 Sep 1;97(35):1304-5. doi: 10.1055/s-0028-1107551.
4
Estramustine phosphate therapy in poorly differentiated carcinoma of the prostate.磷酸雌莫司汀治疗前列腺低分化癌。
Scand J Urol Nephrol Suppl. 1980;55:139-42.
5
Prostatic cancer: diagnosis and prognosis.前列腺癌：诊断与预后
Compr Ther. 1980 Oct;6(10):34-41.
6
[Rate of survival in prostatic cancer with bone metastasis].[前列腺癌骨转移的生存率]
Rev Fr Etud Clin Biol. 1969 Jun-Jul;14(6):609-13.
7
Prostatic adenocarcinoma of ductal origin.导管起源的前列腺腺癌。
Cancer. 1973 Aug;32(2):402-9. doi: 10.1002/1097-0142(197308)32:2<402::aid-cncr2820320218>3.0.co;2-q.
8
[Value of the determination of acid phosphatase of the blood in the diagnosis and prognosis of prostatic diseases. Comparisons of the results obtained with the technic of King and Jegatheesan and the technic of Babson and Read].[血液酸性磷酸酶测定在前列腺疾病诊断和预后中的价值。用金氏和杰加蒂森技术与巴布森和里德技术所得结果的比较]
Presse Med (1893). 1967 Sep 30;75(40):1985-6.
9
[The role of PSA in prostatic adenocarcinoma].[前列腺特异性抗原在前列腺腺癌中的作用]
Minerva Med. 1990 Apr;81(4):261-4.
10
Proceedings: Non-hormonal cytotoxic agents in the treatment of prostatic adenocarcinoma.会议论文：非激素细胞毒性药物治疗前列腺腺癌
Cancer. 1973 Nov;32(5):1131-40. doi: 10.1002/1097-0142(197311)32:5<1131::aid-cncr2820320519>3.0.co;2-n.
本文引用的文献
1
Carcinoma of prostate. Correlation between radiologic quantitation of metastases and patient survival.
Urology. 1975 Jul;6(1):11-6. doi: 10.1016/0090-4295(75)90584-1.
2
Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.
J Urol. 1976 Jan;115(1):86-8. doi: 10.1016/s0022-5347(17)59077-1.
3
Combined serum and bone marrow radioimmunoassays for prostatic acid phosphatase.
J Urol. 1979 Oct;122(4):498-502. doi: 10.1016/s0022-5347(17)56480-0.
4
Reliability of bone marrow acid phosphatase as a parameter of metastatic prostatic cancer.
J Urol. 1979 Aug;122(2):178-9. doi: 10.1016/s0022-5347(17)56314-4.
5
Treatment of metastatic endocrine-unresponsive carcinoma of the prostate gland with multiagent chemotherapy: indicators of response to therapy.多药化疗治疗转移性内分泌无反应性前列腺癌：治疗反应指标
J Natl Cancer Inst. 1979 Sep;63(3):615-22. doi: 10.1093/jnci/63.3.615.
6
Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary report.美法仑、ICRF - 159和羟基脲治疗转移性前列腺癌的评估：初步报告。
Cancer Treat Rep. 1977 Mar-Apr;61(2):311-2.
Zotero 插件